AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in...
Hey traders, My weekly trade idea. The daily price is forming a textbook Cup&Handle formation. After the consolidation in the handle phase, the price is ready to go higher. The momentum will push the price and in my opinion, it is headed to test the all-time high in the 180$ area. The Relative Strength Index broke above its trend line and is moving upward to...
A textbook example of cup&handle pattern forming on ABBV, I think its interesting to dig deeper into the company, as its a defensive stock for just the conditions at the current moment.
Target 200 on 1.618 fib extension. Bottom indicator is correlation to SPY.
Healthcare has been a safe haven for big institutions, with oil hurting this may be a later breakdown following the market
AbbVie has been in this uptrend for multiple years, lets ride. LONG
What Happens when Bearish Harmonic Crabs and Cyphers Meet ?? Of all the major 11 S&P sub-sectors, the Health care (XLV) seems the most technically vunerable. (see insert) Herein we have a well formed Gartley pattern waiting to roll over. Drilling down to the major holdings of this index, AbbVie Inc. (ABBV) also looks the most vulnerable and ready to roll...
Buy ABBV Dec-16-22 $162.5 Strike @ 0.58 Limit to Open
AbbVie - 30d expiry - We look to Sell a break of 132.58 (stop at 137.03) 133 continues to hold back the bears. 132.75 has been pivotal. Posted a Double Bottom formation. A break of the recent low at 132.74 should result in a further move lower. Our profit targets will be 121.01 and 117.01 Resistance: 154 / 157 / 160 Support: 147 / 142 / 137 Disclaimer –...
NYSE:ABBV AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid...
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutics areas such as immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience and also offers treatments for parkinson's, alzheimer's disease. I guess its stock can be down to $142 and below. My trade...
ABBV Buy side liquidity taken. Where is sellside luquidity?
Skew Inverse Head And Shoulders with a target of $174.65. We do see bullish signals momentum wise where 7>21 >200. Bullish Let's just hope a bull market does kick in here as we enter the Christmas season with a Santa Rally.
Notes: * Strong up trend on all time frames * Great earnings track record * Basing for the past ~8 months * Now looking to come up on the right side of its base * Printed a pocket pivot in the last session, indicating institutional buying * Offering an early entry relative to its 50 day line Technicals: Sector: Healthcare - Drug Manufacturers -...
Order BUY ABBV NYSE Stop 145.78 LMT 145.78 will be automatically canceled at 20230401 01:00:00 EST ABBV daily bullish hammer beginning of wave 3 wave 5 uptrend that was ABC correction.
ABBV bullish hammer compression pressure building we can go higher.
The PEAD projected a Neutral outlook for $ABBV after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 100%.